Identification of a proline-rich sequence in the CD2 cytoplasmic domain critical for regulation of integrin-mediated adhesion and activation of phosphoinositide 3-kinase

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5291-5307

  Kivens, Wendy J ^a   Hunt III, Stephen W ^b   Mobley, James L ^a,b   Zell, Traci ^a   Dell, Cheryl L ^b   Bierer, Barbara E ^c   Shimizu, Yoji ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ARTICLE; CELL ADHESION; CELL STRAIN HL 60; ENZYME ACTIVITY; FLOW CYTOMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031841822     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.9.5291     Document Type: Article

References (43)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
2. Arcaro, A., and M. P. Wymann. 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296:297-301.
3. Arroyo, A. G., P. Sanchez-Mateos, M. R. Campanero, I. Martin-Padura, E. Dejana, and F. Sanchez-Madrid. 1992. Regulation of the VLA integrin-ligand interactions through the β1 subunit. J. Cell Biol. 117:659-670.
4. + cells. J. Exp. Med. 173:859-868.
5. Bagnasco, M., J. Nunes, M. Lopez, C. Cerdan, A. Pierres, C. Mawas, and D. Olive. 1989. T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane. Eur. J. Immunol. 19:823-827.
6. lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J. Exp. Med. 183:169-178.
7. Bierer, B. E., and W. C. Hahn. 1993. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. Semin. Immunol. 5:249-261.
8. Bockenstedt, L. K., M. A. Goldsmith, M. Dustin, D. Olive, T. A. Springer, and A. Weiss. 1988. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J. Immunol. 141:1904-1911.
9. Brunn, G. J., J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence, Jr., and R. T. Abraham. 1996. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:5256-5267.
10. Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153-158.
11. Chan, A. S. H., J. L. Mobley, G. B. Fields, and Y. Shimizu. 1997. CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase. J. Immunol. 159:934-942.
12. Chan, A. S. H., P. J. Reynolds, and Y. Shimizu. 1994. Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function. Eur. J. Immunol. 24:2602-2608.
13. Chang, H.-C., P. Moingeon, P. Lopez, H. Krasnow, C. Stebbins, and E. L. Reinherz. 1989. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production. J. Exp. Med. 169:2073-2083.
14. Chang, H.-C., P. Moingeon, R. Pedersen, J. Lucich, C. Stebbins, and E. L. Reinherz. 1990. Involvement of the PPPGHR motif in T cell activation via CD2. J. Exp. Med. 172:351-354.
15. Chen, Q., M. S. Kinch, T. H. Lin, k. Burridge, and R. L. Juliano. 1994. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 269:26602-26605.
16. S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature 370:71-75.
17. Cohen, G. B., R. Ren, and D. Baltimore. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-248.
18. Cross, M. J., A. Stewart, M. N. Hodgkin, D. J. kerr, and M. J. O. Wakelam. 1995. Wortmannin and its structural analogue demethoxyviridin inhibit stimcytokines. J. Biol. Chem. 271:18134-18139.
19. Schwartz, M. A., M. D. Schaller, and M. H. Ginsberg. 1995. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Biol. 11:549-599.
20. Serve, H., N. S. Yee, G. Stella, L. Sepp-Lorenzino, J. C. Tan, and P. Besmer. 1995. Differential roles of PI 3-kinase and kit tyrosine 821 in kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14: 473-483.
21. Shaw, L. M., I. Rabinovitz, H. H. F. Wang, A. Toker, and A. M. Mercurio. 1997. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell 91:949-960.
22. Shimizu, Y., and S. W. Hunt III. 1996. Regulating integrin-mediated adhesion: one more function for PI 3-kinase? Immunol. Today 17:565-573.
23. + T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-l and invasin. J. Immunol. 151:4106-4115.
24. Shimizu, Y., J. L. Mobley, L. D. Finkelstein, and A. S. H. Chan. 1995. A role for phosphatidylinositol 3-kinase in the regulation of β1 integrin activity by the CD2 antigen. J. Cell Biol. 131:1867-1880.
25. Shimizu, Y., G. A. van Seventer, E. Ennis, W. Newman, K. J. Horgan, and S. Shaw. 1992. Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J. Exp. Med. 175:577-582.
26. Shimizu, Y., G. A. van Seventer, K. J. Horgan, and S. Shaw. 1990. Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 345:250-253.
27. Siliciano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and E. L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317:428-430.
28. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434.
29. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314.
30. Stephens, L., A. Smrcka, F. T. Cooke, T. R. Jackson, P. C. Sternweis, and P. T. Hawkins. 1994. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell 77:83-93.
31. Stoyanov, B., S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S. Stoyanova, B. Vanhaesebroeck, R. Dhand, B. Nurnberg, P. Gierschik, K. Seedorf, J. J. Hsuan, M. D. Waterfield, and R. Wetzker. 1995. Cloning and characterization of a G protein-activated human phosphoinositide 3-kinase. Science 269:690-693.
32. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79-82.
33. Tanaka, Y., S. M. Albelda, K. J. Horgan, G. A. van Seventer, Y. Shimizu, W. Newman, J. Hallam, P. J. Newman, C. A. Buck, and S. Shaw. 1992. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J. Exp. Med. 176:245-253.
34. Thomas, J. E., M. Venugopalan, R. Galvin, Y. Wang, G. M. Bokoch, and C. J. Vlahos. 1997. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. J. Cell. Biochem. 64:182-195.
35. Urich, M., M. Y. M. El Shemerly, D. Besser, Y. Nagamine, and K. Ballmer-Hofer. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
36. van Kooyk, Y., P. van de Wiel-van Kemenade, P. Weder, T. W. Kuijpers, and C. G. Figdor. 1989. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342:811-813.
37. Vanhaesebroeck, B., M. J. Welham, K. Kotani, R. Stein, P. H. Warne, M. J. Zvelebil, K. Higashi, S. Volinia, J. Downward, and M. D. Waterfield. 1997. p110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. USA 94:4330-4335.
38. Vlahos, C. J., W. F. Matter, R. F. Brown, A. E. Traynor-Kaplan, P. G. Heyworth, E. R. Prossnitz, R. D. Ye, P. Marder, J. A. Schelm, K. J. Rothfuss, B. S. Serlin, and P. J. Simpson. 1995. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154:2413-2422.
39. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241-5248.
40. Von Willebrand, M., T. Jascur, N. Bonnefoy-Bérard, H. Yano, A. Altman, Y. Matsuda, and T. Mustelin. 1996. Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor CD3-induced activation of the mitogen-activated kinase Erk2. Eur. J. Biochem. 235:828-835.
41. Ward, S. G., C. H. June, and D. Olive. 1996. PI 3-kinase: a pivotal pathway in T-cell activation? Immunol. Today 17:187-197.
42. Weiss, M. J., J. F. Daley, J. C. Hodgdon, and E. L. Reinherz. 1984. Calcium dependency of antigen-specific (T3-Ti) and alternative (T11) pathways of human T-cell activation. Proc. Natl. Acad. Sci. USA 81:6836-6840.
43. Zell, T., S. W. Hunt III, L. D. Finkelstein, and Y. Shimizu. 1996. CD28-mediated upregulation of β1 integrin-mediated adhesion involves phosphatidylinositol 3-kinase. J. Immunol. 156:883-886.